AI-generated peptide research articles. Updated weekly.
The incretin-based therapeutic landscape has evolved rapidly over the past decade, moving from single GLP-1 receptor agonists to dual agonists like tirzepatide. Now, a new molecule is pushing the boundaries even further. Retatrutide (LY3437943),
Few peptides in the research landscape have generated as much sustained interest as BPC-157 (Body Protection Compound-157). First isolated from human gastric juice in the early 1990s, this 15-amino-acid peptide has accumulated a remarkable volume
The SURMOUNT clinical trial program represents one of the most comprehensive evaluations of an anti-obesity medication ever conducted. Spanning multiple Phase 3 studies enrolling thousands of participants, this program established tirzepatide as
The difference between 98% and 99% purity on a certificate of analysis might seem trivial — just one percentage point. But that single digit can represent a meaningful shift in impurity load, research reliability, and downstream biological effects. F
The intersection of NAD+ biology and peptide science represents one of the more intriguing frontiers in longevity research. As our understanding of cellular energy metabolism deepens, researchers are exploring whether specific peptides can amplify or
The landscape of luteinizing hormone (LH) stimulation has shifted dramatically in recent years. With the FDA's crackdown on compounded human chorionic gonadotropin (HCG) beginning in 2020, researchers and clinicians have increasingly turned to **
The research peptide market has exploded in recent years, driven by growing interest in compounds like BPC-157, TB-500, and various secretagogues. But this rapid growth has created a fragmented landscape where product quality varies enormousl
The discovery that mitochondria encode bioactive peptides has fundamentally shifted our understanding of cellular metabolism. Among these mitochondrial-derived peptides (MDPs), MOTS-c stands out as a particularly compelling molecule — one that ap
The practice of combining multiple peptides into coordinated protocols — commonly known as "stacking" — has become increasingly prevalent among researchers and self-experimenters. The underlying logic is straightforward: if individual peptides target
The human body produces a remarkable arsenal of endogenous defense molecules, and few have attracted as much research attention as the sole cathelicidin-derived antimicrobial peptide found in humans. LL-37, a 37-amino acid peptide cleaved from th
Choosing the right solvent for peptide reconstitution is one of the most overlooked yet critical decisions in peptide research. Using the wrong diluent can degrade your compound within hours, compromise sterility, or introduce confounding variables i
The landscape of incretin-based therapies has evolved rapidly, moving from single-receptor agonists to dual and now triple agonists. Semaglutide, Tirzepatide, and Retatrutide represent three successive generations of this evolution, each
Few peptides have generated as much intrigue — and controversy — in the nootropic community as Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide). Originally developed at Washington State University by Dr. Joseph Harding and colleagues, this hex
The difference between reckless self-experimentation and meaningful personal research often comes down to one thing: documentation. In the world of peptide science, where individual responses vary dramatically and subtle effects unfold over weeks or
Growth hormone (GH) has long been a focal point of anti-aging research, body composition optimization, and recovery science. But exogenous GH injections are expensive, require refrigeration, and carry well-documented risks of supraphysiological dosin
Research peptides occupy a unique space in experimental science — they're potent, sequence-specific signaling molecules that demand respect in handling, preparation, and administration. Yet the growing accessibility of synthetic peptides has outpaced
The peptide therapeutics landscape has shifted dramatically over the past twelve months. From next-generation obesity drugs entering phase III trials to breakthrough results in longevity signaling and antimicrobial peptides, 2025 has delivered some o
Growth hormone (GH) secretion declines progressively with age — a phenomenon often referred to as somatopause. By age 60, many adults produce less than half the GH they did at age 25, contributing to changes in body composition, sleep quality, sk
The rapid adoption of GLP-1 receptor agonists for metabolic research has raised a critical question in the scientific community: how much of the weight lost on these compounds comes from fat, and how much comes from lean tissue? For researchers and b
Precision matters in peptide research. Whether reconstituting lyophilized peptides or drawing microliter-level doses, the syringe you choose directly impacts accuracy, waste, and reproducibility. Insulin syringes are the most common tool for subcutan
Alpha-melanocyte-stimulating hormone (α-MSH) has long been recognized as one of the body's most potent endogenous anti-inflammatory signals. But the full 13-amino-acid peptide presents challenges for therapeutic development — including receptor-media
Gradual dose escalation isn't just a suggestion with semaglutide — it's a carefully engineered protocol that directly impacts tolerability, efficacy, and long-term adherence. Whether studied in the context of type 2 diabetes or obesity, the clini
The search for interventions that address aging at its molecular roots has led researchers to investigate a class of short regulatory peptides known as bioregulators. Among the most studied is Epithalon (also spelled Epitalon), a synthetic tetrap
The promise of peptide-based therapeutics hinges not just on the molecule itself but on how effectively it reaches its target. A peptide with extraordinary binding affinity is worthless if it's degraded in the gut, blocked by the skin barrier, or cle
Growth hormone secretagogues (GHS) have been a subject of intense pharmacological interest since the discovery that synthetic peptides could stimulate pituitary GH release independent of growth hormone-releasing hormone (GHRH). Among this class, **he
Cycling protocols are one of the most debated topics in peptide research, yet surprisingly little standardized guidance exists. Unlike small-molecule pharmaceuticals with well-defined prescribing information, many research peptides lack consensus on
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide first isolated from the cerebral venous blood of rabbits during induced sleep in 1977. Identified by Schoenenberger and Monnier,
Gastrointestinal side effects remain the most common reason people discontinue GLP-1 receptor agonist therapy. While semaglutide and tirzepatide have demonstrated remarkable efficacy in clinical trials, their tolerability profiles deserve car
The thymus gland has long been recognized as a central organ of the adaptive immune system, yet its endocrine functions remained poorly understood until the 1970s. It was during this period that Thymosin Alpha-1 (Tα1) was first isolated from thym
In the research peptide market, third-party lab reports — commonly called Certificates of Analysis (CoAs) — are the single most important tool for verifying what's actually in a vial. Yet many researchers and biohackers glance at these documents with
Among the growing landscape of peptide therapeutics, tesamorelin holds a distinctive position as one of the few growth hormone-releasing hormone (GHRH) analogs to achieve full FDA approval. Marketed under the brand name Egrifta®, tesamorelin
Researchers who work with peptides quickly learn a frustrating reality: the moment you add bacteriostatic water to a lyophilized vial, a countdown begins. That stable, shelf-friendly powder transforms into a fragile molecule in solution, vulnerable t
The pursuit of skin pigmentation without ultraviolet exposure has driven decades of peptide research, beginning with work at the University of Arizona in the 1980s. Melanotan II (MT-II) emerged from that research as a synthetic analog of alpha-me
Peptide purity is about more than just sequence fidelity. While researchers often focus on peptide content and amino acid identity, one of the most critical — and frequently overlooked — aspects of quality assurance is heavy metal contamination testi
Among the growing catalog of synthetic peptides under investigation, two stand out for their unique origins and overlapping yet distinct neurocognitive profiles. Selank and Semax were both developed at the Institute of Molecular Genetics of t
The search for targeted fat-loss agents has long driven pharmaceutical research, and few peptides illustrate the promise — and complexity — of that pursuit quite like AOD-9604. This modified fragment of human growth hormone (hGH) was designed to
The incretin-based obesity pharmacotherapy landscape has evolved rapidly — from single GLP-1 receptor agonists like semaglutide, to dual agonists like tirzepatide, and now to a triple-hormone approach that may redefine the upper boundary of pharmacol
Subcutaneous injection is the primary route of administration for most research peptides, from BPC-157 and thymosin beta-4 to semaglutide and tesamorelin. While much attention is paid to dosing protocols and reconstitution techniques,
Growth hormone releasing peptides (GHRPs) represent a class of synthetic hexapeptides that stimulate the anterior pituitary to release growth hormone (GH) through activation of the ghrelin receptor (GHS-R1a). Among the most widely studied members of
Sexual dysfunction remains one of the most undertreated conditions in medicine, particularly for women. While phosphodiesterase-5 inhibitors like sildenafil revolutionized treatment for erectile dysfunction by targeting vascular mechanisms, they offe
Accurate reconstitution and measurement represent the single most critical skill in peptide research. Unlike pharmaceutical tablets with pre-measured doses, lyophilized peptides require researchers to calculate concentrations, select appropriate syri
Peptides are inherently fragile molecules. Their biological activity depends on precise three-dimensional structures that can be disrupted by something as simple as leaving a vial on a countertop for too long. Whether you're managing a research lab i
The tripeptide glycyl-L-histidyl-L-lysine was first isolated from human plasma in 1973 by Dr. Loren Pickart, who observed that aged liver tissue exposed to this peptide began synthesizing proteins at rates comparable to younger tissue. When bound to
The incretin-based therapy landscape has shifted dramatically with the emergence of two blockbuster peptides targeting overlapping but distinct receptor pathways. Semaglutide, a GLP-1 receptor agonist, and Tirzepatide, a dual GLP-1/GIP recept
Growth hormone (GH) optimization remains one of the most actively researched areas in peptide science. Rather than relying on exogenous GH administration, researchers have increasingly explored compounds that stimulate the body's own pulsatile GH rel
For anyone sourcing research peptides outside of pharmaceutical supply chains, third-party analytical testing is the single most important quality assurance tool available. Among independent testing services, Janoshik Analytical has become one of the
The glucagon-like peptide-1 (GLP-1) receptor agonist class has fundamentally reshaped obesity research over the past decade. Among these compounds, semaglutide has emerged as the most extensively studied, producing weight loss outcomes in clinica
Among peptide research circles, few combinations generate as much discussion as the pairing of BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment). Both peptides have independently demonstrated tissue-repair propertie
Thymosin Beta-4 (Tβ4) is a 43-amino acid peptide that plays a fundamental role in cellular processes ranging from actin polymerization to wound healing. Originally isolated from the thymus gland, this naturally occurring peptide has become one of the
The route of administration can fundamentally alter how a peptide behaves in the body — affecting absorption kinetics, bioavailability, onset of action, and even side effect profiles. For researchers and self-administering biohackers alike, the choic
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. Consisting of 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, it
Most research peptides arrive as lyophilized (freeze-dried) powders — fragile, lightweight cakes or puffs sitting at the bottom of small glass vials. Before they can be used in any experimental protocol, they must be reconstituted: dissolved back int
Peptides are among the most actively studied molecules in modern biomedical research, yet they remain widely misunderstood. Often confused with proteins, steroids, or even small-molecule drugs, peptides occupy a unique space in biochemistry — small e